AAAAAA

   
Results: 1-22 |
Results: 22
IMMUNE-RESPONSES OF INFANTS TO INFECTION WITH RESPIRATORY VIRUSES ANDLIVE ATTENUATED RESPIRATORY VIRUS CANDIDATE VACCINES
Authors: CROWE JE
Citation: Je. Crowe, IMMUNE-RESPONSES OF INFANTS TO INFECTION WITH RESPIRATORY VIRUSES ANDLIVE ATTENUATED RESPIRATORY VIRUS CANDIDATE VACCINES, Vaccine, 16(14-15), 1998, pp. 1423-1432
ISOLATION OF A 2ND RECOMBINANT HUMAN RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL-ANTIBODY FRAGMENT (FAB RSVF2-5) THAT EXHIBITS THERAPEUTIC EFFICACY IN-VIVO
Authors: CROWE JE GILMOUR PS MURPHY BR CHANOCK RM DUAN LX POMERANTZ RJ PILKINGTON GR
Citation: Je. Crowe et al., ISOLATION OF A 2ND RECOMBINANT HUMAN RESPIRATORY SYNCYTIAL VIRUS MONOCLONAL-ANTIBODY FRAGMENT (FAB RSVF2-5) THAT EXHIBITS THERAPEUTIC EFFICACY IN-VIVO, The Journal of infectious diseases, 177(4), 1998, pp. 1073-1076
THE TEMPERATURE-SENSITIVE (TS) PHENOTYPE OF A COLD-PASSAGED (CP) LIVEATTENUATED RESPIRATORY SYNCYTIAL VIRUS-VACCINE CANDIDATE, DESIGNATED CPTS530, RESULTS FROM A SINGLE AMINO-ACID SUBSTITUTION IN THE L-PROTEIN (VOL 71, PG 5814, 1997)
Authors: JUHASZ K WHITEHEAD SS BUI PT BIGGS JM CROWE JE BOULANGER CA COLLINS PL MURPHY BR
Citation: K. Juhasz et al., THE TEMPERATURE-SENSITIVE (TS) PHENOTYPE OF A COLD-PASSAGED (CP) LIVEATTENUATED RESPIRATORY SYNCYTIAL VIRUS-VACCINE CANDIDATE, DESIGNATED CPTS530, RESULTS FROM A SINGLE AMINO-ACID SUBSTITUTION IN THE L-PROTEIN (VOL 71, PG 5814, 1997), Journal of virology, 71(11), 1997, pp. 8953-8953
EVALUATION OF 2 LIVE, COLD-PASSAGED, TEMPERATURE-SENSITIVE RESPIRATORY SYNCYTIAL VIRUS-VACCINES IN CHIMPANZEES AND IN HUMAN ADULTS, INFANTS, AND CHILDREN
Authors: KARRON RA WRIGHT PF CROWE JE CLEMENTSMANN ML THOMPSON J MAKHENE M CASEY R MURPHY BR
Citation: Ra. Karron et al., EVALUATION OF 2 LIVE, COLD-PASSAGED, TEMPERATURE-SENSITIVE RESPIRATORY SYNCYTIAL VIRUS-VACCINES IN CHIMPANZEES AND IN HUMAN ADULTS, INFANTS, AND CHILDREN, The Journal of infectious diseases, 176(6), 1997, pp. 1428-1436
THE ROLE OF ANTIBODIES IN RESPIRATORY VIRAL IMMUNITY
Authors: CROWE JE
Citation: Je. Crowe, THE ROLE OF ANTIBODIES IN RESPIRATORY VIRAL IMMUNITY, Seminars in virology, 7(4), 1996, pp. 273-283
ACQUISITION OF THE TS PHENOTYPE BY A CHEMICALLY MUTAGENIZED COLD-PASSAGED HUMAN RESPIRATORY SYNCYTIAL VIRUS-VACCINE CANDIDATE RESULTS FROM THE ACQUISITION OF A SINGLE MUTATION IN THE POLYMERASE (L) GENE
Authors: CROWE JE FIRESTONE CY WHITEHEAD SS COLLINS PL MURPHY BR
Citation: Je. Crowe et al., ACQUISITION OF THE TS PHENOTYPE BY A CHEMICALLY MUTAGENIZED COLD-PASSAGED HUMAN RESPIRATORY SYNCYTIAL VIRUS-VACCINE CANDIDATE RESULTS FROM THE ACQUISITION OF A SINGLE MUTATION IN THE POLYMERASE (L) GENE, Virus genes, 13(3), 1996, pp. 269-273
NUCLEOTIDE-SEQUENCE ANALYSIS OF THE RESPIRATORY SYNCYTIAL VIRUS SUBGROUP A COLD-PASSAGED (CP) TEMPERATURE-SENSITIVE (TS) CPTS-248 404 LIVE ATTENUATED VIRUS-VACCINE CANDIDATE/
Authors: FIRESTONE CY WHITEHEAD SS COLLINS PL MURPHY BR CROWE JE
Citation: Cy. Firestone et al., NUCLEOTIDE-SEQUENCE ANALYSIS OF THE RESPIRATORY SYNCYTIAL VIRUS SUBGROUP A COLD-PASSAGED (CP) TEMPERATURE-SENSITIVE (TS) CPTS-248 404 LIVE ATTENUATED VIRUS-VACCINE CANDIDATE/, Virology, 225(2), 1996, pp. 419-422
LIVE SUBGROUP-B RESPIRATORY SYNCYTIAL VIRUS-VACCINES THAT ARE ATTENUATED, GENETICALLY STABLE, AND IMMUNOGENIC IN RODENTS AND NONHUMAN-PRIMATES
Authors: CROWE JE BUI PT FIRESTONE CY CONNORS M ELKINS WR CHANOCK RM MURPHY BR
Citation: Je. Crowe et al., LIVE SUBGROUP-B RESPIRATORY SYNCYTIAL VIRUS-VACCINES THAT ARE ATTENUATED, GENETICALLY STABLE, AND IMMUNOGENIC IN RODENTS AND NONHUMAN-PRIMATES, The Journal of infectious diseases, 173(4), 1996, pp. 829-839
PROGRESS TOWARD THE DEVELOPMENT OF A LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE
Authors: MURPHY BR CROWE JE BUI PT ELKINS WR FIRESTONE CY CHANOCK RM LUBECK MD KARRON R CLEMENTS ML WRIGHT PF SIBER GR
Citation: Br. Murphy et al., PROGRESS TOWARD THE DEVELOPMENT OF A LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE, Journal of cellular biochemistry, 1995, pp. 274-274
COLD PASSAGED, TEMPERATURE-SENSITIVE MUTANTS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) ARE HIGHLY ATTENUATED, IMMUNOGENIC, AND PROTECTIVE IN SERONEGATIVE CHIMPANZEES, EVEN WHEN RSV ANTIBODIES ARE INFUSED SHORTLY BEFORE IMMUNIZATION
Authors: CROWE JE BUI PT SIBER GR ELKINS WR CHANOCK RM MURPHY BR
Citation: Je. Crowe et al., COLD PASSAGED, TEMPERATURE-SENSITIVE MUTANTS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) ARE HIGHLY ATTENUATED, IMMUNOGENIC, AND PROTECTIVE IN SERONEGATIVE CHIMPANZEES, EVEN WHEN RSV ANTIBODIES ARE INFUSED SHORTLY BEFORE IMMUNIZATION, Vaccine, 13(9), 1995, pp. 847-855
ISOLATION AND CHARACTERIZATION OF A HIGHLY ATTENUATED RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE CANDIDATE BY MUTAGENESIS OF THE INCOMPLETELY ATTENUATED RSV A2 TS-1 NG-1 MUTANT VIRUS
Authors: HSU KHL CROWE JE LUBECK MD DAVIS AR HUNG PP CHANOCK RM MURPHY BR
Citation: Khl. Hsu et al., ISOLATION AND CHARACTERIZATION OF A HIGHLY ATTENUATED RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE CANDIDATE BY MUTAGENESIS OF THE INCOMPLETELY ATTENUATED RSV A2 TS-1 NG-1 MUTANT VIRUS, Vaccine, 13(5), 1995, pp. 509-515
CURRENT APPROACHES TO THE DEVELOPMENT OF VACCINES AGAINST DISEASE CAUSED BY RESPIRATORY SYNCYTIAL VIRUS (RSV) AND PARAINFLUENZA VIRUS (PIV)- A MEETING REPORT OF THE WHO PROGRAM FOR VACCINE DEVELOPMENT
Authors: CROWE JE
Citation: Je. Crowe, CURRENT APPROACHES TO THE DEVELOPMENT OF VACCINES AGAINST DISEASE CAUSED BY RESPIRATORY SYNCYTIAL VIRUS (RSV) AND PARAINFLUENZA VIRUS (PIV)- A MEETING REPORT OF THE WHO PROGRAM FOR VACCINE DEVELOPMENT, Vaccine, 13(4), 1995, pp. 415-421
A COLD-PASSAGED, ATTENUATED STRAIN OF HUMAN RESPIRATORY SYNCYTIAL VIRUS CONTAINS MUTATIONS IN THE F-GENES AND L-GENES
Authors: CONNORS M CROWE JE FIRESTONE CY MURPHY BR COLLINS PL
Citation: M. Connors et al., A COLD-PASSAGED, ATTENUATED STRAIN OF HUMAN RESPIRATORY SYNCYTIAL VIRUS CONTAINS MUTATIONS IN THE F-GENES AND L-GENES, Virology, 208(2), 1995, pp. 478-484
LIVE ATTENUATED MUTANTS OF RESPIRATORY SYNCYTIAL VIRUS (RSV) - IN-VITRO MARKERS AND REPLICATION IN MICE OR CHIMPANZEES CORRELATE WITH LEVELOF ATTENUATION FOR SERONEGATIVE HUMAN INFANTS
Authors: CROWE JE BUI PT KARRON RA CLEMENTS ML WRIGHT PF CHANOCK RM MURPHY BR
Citation: Je. Crowe et al., LIVE ATTENUATED MUTANTS OF RESPIRATORY SYNCYTIAL VIRUS (RSV) - IN-VITRO MARKERS AND REPLICATION IN MICE OR CHIMPANZEES CORRELATE WITH LEVELOF ATTENUATION FOR SERONEGATIVE HUMAN INFANTS, Pediatric research, 37(4), 1995, pp. 172-172
CYTOTOXIC T-CELLS SPECIFIC FOR A SINGLE PEPTIDE ON THE M2 PROTEIN OF RESPIRATORY SYNCYTIAL VIRUS ARE THE SOLE MEDIATORS OF RESISTANCE INDUCED BY IMMUNIZATION WITH M2 ENCODED BY A RECOMBINANT VACCINIA VIRUS
Authors: KULKARNI AB COLLINS PL BACIK I YEWDELL JW BENNINK JR CROWE JE MURPHY BR
Citation: Ab. Kulkarni et al., CYTOTOXIC T-CELLS SPECIFIC FOR A SINGLE PEPTIDE ON THE M2 PROTEIN OF RESPIRATORY SYNCYTIAL VIRUS ARE THE SOLE MEDIATORS OF RESISTANCE INDUCED BY IMMUNIZATION WITH M2 ENCODED BY A RECOMBINANT VACCINIA VIRUS, Journal of virology, 69(2), 1995, pp. 1261-1264
ISOLATION AND CHARACTERIZATION OF A CHIMPANZEE MONOCLONAL-ANTIBODY TOTHE G-GLYCOPROTEIN OF HUMAN RESPIRATORY SYNCYTIAL VIRUS
Authors: CROWE JE CHEUNG PYK WALLACE EF CHANOCK RM LARRICK JW MURPHY BR FRY K
Citation: Je. Crowe et al., ISOLATION AND CHARACTERIZATION OF A CHIMPANZEE MONOCLONAL-ANTIBODY TOTHE G-GLYCOPROTEIN OF HUMAN RESPIRATORY SYNCYTIAL VIRUS, Clinical and diagnostic laboratory immunology, 1(6), 1994, pp. 701-706
A FURTHER ATTENUATED DERIVATIVE OF A COLD-PASSAGED TEMPERATURE-SENSITIVE MUTANT OF HUMAN RESPIRATORY SYNCYTIAL VIRUS RETAINS IMMUNOGENICITYAND PROTECTIVE EFFICACY AGAINST WILD-TYPE CHALLENGE IN SERONEGATIVE CHIMPANZEES
Authors: CROWE JE BUI PT DAVIS AR CHANOCK RM MURPHY BR
Citation: Je. Crowe et al., A FURTHER ATTENUATED DERIVATIVE OF A COLD-PASSAGED TEMPERATURE-SENSITIVE MUTANT OF HUMAN RESPIRATORY SYNCYTIAL VIRUS RETAINS IMMUNOGENICITYAND PROTECTIVE EFFICACY AGAINST WILD-TYPE CHALLENGE IN SERONEGATIVE CHIMPANZEES, Vaccine, 12(9), 1994, pp. 783-790
SATISFACTORILY ATTENUATED AND PROTECTIVE MUTANTS DERIVED FROM A PARTIALLY ATTENUATED COLD-PASSAGED RESPIRATORY SYNCYTIAL VIRUS MUTANT BY INTRODUCTION OF ADDITIONAL ATTENUATING MUTATIONS DURING CHEMICAL MUTAGENESIS
Authors: CROWE JE BUI PT LONDON WT DAVIS AR HUNG PP CHANOCK RM MURPHY BR
Citation: Je. Crowe et al., SATISFACTORILY ATTENUATED AND PROTECTIVE MUTANTS DERIVED FROM A PARTIALLY ATTENUATED COLD-PASSAGED RESPIRATORY SYNCYTIAL VIRUS MUTANT BY INTRODUCTION OF ADDITIONAL ATTENUATING MUTATIONS DURING CHEMICAL MUTAGENESIS, Vaccine, 12(8), 1994, pp. 691-699
AN UPDATE ON APPROACHES TO THE DEVELOPMENT OF RESPIRATORY SYNCYTIAL VIRUS (RSV) AND PARAINFLUENZA VIRUS TYPE-3 (PIV3) VACCINES
Authors: MURPHY BR HALL SL KULKARNI AB CROWE JE COLLINS PL CONNORS M KARRON RA CHANOCK RM
Citation: Br. Murphy et al., AN UPDATE ON APPROACHES TO THE DEVELOPMENT OF RESPIRATORY SYNCYTIAL VIRUS (RSV) AND PARAINFLUENZA VIRUS TYPE-3 (PIV3) VACCINES, Virus research, 32(1), 1994, pp. 13-36
RECOMBINANT HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) MONOCLONAL-ANTIBODY FAB IS EFFECTIVE THERAPEUTICALLY WHEN INTRODUCED DIRECTLY INTO THE LUNGS OF RSV-INFECTED MICE
Authors: CROWE JE MURPHY BR CHANOCK RM WILLIAMSON RA BARBAS CF BURTON DR
Citation: Je. Crowe et al., RECOMBINANT HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) MONOCLONAL-ANTIBODY FAB IS EFFECTIVE THERAPEUTICALLY WHEN INTRODUCED DIRECTLY INTO THE LUNGS OF RSV-INFECTED MICE, Proceedings of the National Academy of Sciences of the United Statesof America, 91(4), 1994, pp. 1386-1390
HUMAN MONOCLONAL-ANTIBODY FAB FRAGMENTS CLONED FROM COMBINATORIAL LIBRARIES - POTENTIAL USEFULNESS IN PREVENTION AND OR TREATMENT OF MAJOR HUMAN VIRAL DISEASES/
Authors: CHANOCK RM CROWE JE MURPHY BR BURTON DR
Citation: Rm. Chanock et al., HUMAN MONOCLONAL-ANTIBODY FAB FRAGMENTS CLONED FROM COMBINATORIAL LIBRARIES - POTENTIAL USEFULNESS IN PREVENTION AND OR TREATMENT OF MAJOR HUMAN VIRAL DISEASES/, Infectious agents and disease, 2(3), 1993, pp. 118-131
A COMPARISON IN CHIMPANZEES OF THE IMMUNOGENICITY AND EFFICACY OF LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS (RSV) TEMPERATURE-SENSITIVE MUTANT VACCINES AND VACCINIA VIRUS RECOMBINANTS THAT EXPRESS THE SURFACE GLYCOPROTEINS OF RSV
Authors: CROWE JE COLLINS PL LONDON WT CHANOCK RM MURPHY BR
Citation: Je. Crowe et al., A COMPARISON IN CHIMPANZEES OF THE IMMUNOGENICITY AND EFFICACY OF LIVE ATTENUATED RESPIRATORY SYNCYTIAL VIRUS (RSV) TEMPERATURE-SENSITIVE MUTANT VACCINES AND VACCINIA VIRUS RECOMBINANTS THAT EXPRESS THE SURFACE GLYCOPROTEINS OF RSV, Vaccine, 11(14), 1993, pp. 1395-1404
Risultati: 1-22 |